Vos T,Abajobir AA,Abate KH,Abbafati C,Abbas KM,Abdallah F .2017 .a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100) : 1211-59.
UlI RE,Satyana RP,Zomer E,Magliano D,Liew D .2020 .Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling. BMJ open, 10 : e039221.
Poledniczek M,Neumayer C,KopP CW,Schlager O,GremmeL T,Jozkowicz A .2023 .Micro-. Macrovascular Effects of Inflammation in Peripheral Artery Disease-Pathophysiology and Translational Therapeutic Approaches. Biomedicines, 11 : 2284-7.
El-Hasbani G,Jawad A,Uthman I. Colchicine: .2021 .An ancient drug with multiple benefits. Curr Pharmaceut Design, 27 : 2917-24.
Cirillo P,Conte S,Pellegrino G,Barra G,De Palma R,Sugraliyev A .2022 .Effects of colchicine on tissue factor in oxldlactivated T-lymphocytes. J Thrombosis Thrombolysis, 53 : 1-11.
Ravelli RB,Gigant B,Curmi pa,Jourdain I,Lachkar S,Sobel A .2004 .Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature, 428 : 198-202.
Tardif ,Kouz S,Waters DD,Bertrand OF,Diaz R,Maggioni AP .2019 .Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med, 381 : 2497-505.
Al-Abdouh A,Barbarawi M,Khan SU,Osman M,Upadhrasta S,Solipuram V .2021 .Colchicine therapy in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Coronary Artery Dis, 32 : 441-7.
Ullah W,Gowda SN,Fischman D .2021 .Safety and efficacy of colchicine in patients with coronary artery disease: a systematic review and meta-analysis. Cardiovasc Revascularization Med, 23 : 1-6.
Page MJ,Mckenzie JE,Bossuyt PM,Boutron I,Hoffmann TC,Mulrow CD .2021 .The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372 : n71.
Sterne JA,Savović J,Page MJ,Elbers RG,Blencowe NS,Boutron I .2019 .Rob 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366 : 14898.
West SL,Gartlehner G,Mansfield AJ,Poole C,Tant E,Lenfestey N . .Comparative effectiveness review methods: clinical heterogeneity. Agency for Healthcare Research and Quality (US), Rockville (MD); 2010. , 21433337 : .
Aslanabadi N,Khiali s,Joudi S,Mamdouhi M,Entezarimaleki T .2021 .Colchicine for the prevention of myocardial injury following elective PCI: a randomized clinical trial. Pharmaceut Sci, 28 : 596-602.
Pan T,Jiang C-Y,Zhang H,Han X-K H-T,Jiang XY .2023 .The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial. Crit Care, 27 : 49-54.
Sellakannu S,Sharma YP,Panda PK,Mehrotra S,Rana S,Sharma S .2023 .Effects of low dose colchicine in patients of Coronary artery disease undergoing percutaneous coronary intervention. Indian Heart J, 75 : S16-S7.
Shah B,Pillinger M,Zhong H,Cronstein B,Xia Y,Lorin JD .2020 .Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention. Circulation, 13(4) : e008717.
Tong DC,Quinn S,Nasis A,Hiew C,Roberts-thomson P,Adams H .2020 .Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation, 142 : 1890-900.
Van Broekhoven A,Mohammadnia N,Silvis MJ,Los J,Fiolet AT,Opstal TS .2022 .The effect of years-long exposure to low-dose colchicine on renal and liver function and blood creatine kinase levels: safety insights from the low-dose colchicine 2 (lodoco2) trial. Clin Drug Invest, 42 : 977-85.
Mewton N,Roubille F,Bresson D,Prieur C,Bouleti C,Bochaton T .2021 .. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation, 144 : 859-69.
Nidorf SM,Eikelboom JW,Budgeon CA,Thompson PL .2013 .Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol, 61 : 404-10.
Nidorf SM,Fiolet ATL,Mosterd A,Eikelboom JW,Schut A,Opstal TSJ .2020 .Colchicine in patients with chronic coronary disease. N Engl J Med, 383 : 1838-47.
Kofler T,Kurmann R,Lehnick D,Cioffi GM,Chandran S,Attinger‐toller A .2021 .Colchicine in patients with coronary artery disease: a systematic review and meta‐analysis of randomized trials. J Am Heart Assoc, 10 : e021198.
Chen T,Liu G,Yu B. .2023 .A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease. Clin Res Cardiol, 112 : 1487-505.
Ma Z,Chen J,Jin K,Chen X .2022 .Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials. Front Cardiovasc Med, 9 : 947959.
Xu H,Mao L,Liu H,Lin Z,Zhang Y,Yang J .2022 .Colchicine for Secondary prevention of coronary artery disease: a metaanalysis of randomised controlled trials. Heart Lung Circulation, 31 : 685-95.